Compare Medpace Holdings Inc (MEDP) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs United States Oil ETF — how do they compare? Medpace Holdings Inc trades at $611.57 (market cap $16.82B), while United States Oil ETF trades at $148.3 (market cap $1.90B). The key difference: Medpace Holdings Inc is far larger — about 8.9× United States Oil ETF's market cap, and Medpace Holdings Inc is more actively traded (223,093 versus 5,932,922). Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and United States Oil ETF for 21 Days on average.
| MEDP | USO | |
|---|---|---|
Market Cap | $16.82B | $1.90B |
Volume | 223,093 | 5,932,922 |
Sector | Health | — |
52-Week High | $630.19 | $161.86 |
52-Week Low | $393.42 | $66.17 |
Typical Hold Time | 14 Days | 21 Days |
Enterprise Value | $16.44B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medpace (MEDP) trades at $617.47, up 2.19% with strong quarterly earnings beats and robust profitability metrics. The stock shows neutral technical signals with key resistance at $620, while fundamentals reveal impressive ROE of 162.15% and consistent revenue growth to $2.8B projected for 2026. Recent CEO stock sales and mixed institutional activity create balanced sentiment ahead of Q3 earnings announcement on October 21, 2026.
MEDP presents growth potential with analyst consensus target of $620.44 and strong historical execution, though elevated valuations (P/E 35.41) and insider selling warrant caution. The stock's upside depends on continued earnings delivery amid competitive medical services landscape.
USO shows strong momentum with a 2.98% gain to $148.20, supported by bullish technical signals including positive moving averages and key resistance at $150. The oil sector faces mixed fundamentals with OPEC+ maintaining steady output while geopolitical tensions in the Middle East create supply uncertainty. Recent news highlights attacks on oil infrastructure and G-7 reserve releases impacting global oil markets.
The stock presents upside potential toward $152-154 resistance levels, though risks include oil price volatility from geopolitical events and potential supply disruptions. Investor sentiment remains cautiously optimistic given the technical strength, but fundamental clarity on earnings and margins is needed for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
